Maks Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in New Delhi, Delhi, India, established in 1998.
1998 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Maks Pharmaceuticals Private Limited

Maks Pharmaceuticals Private Limited, a active private limited company, was established on 21 April 1998 in New Delhi, Delhi, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U24232DL1998PTC093355. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Anju Aggarwal (Director), Madhusudan Agarwal (Director). Past directors included Manu Agarwal, Sumit Agarwal. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H-47 Naveen Shahdara, New Delhi, Delhi, 110032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL1998PTC093355

  • Registration Number

    093355

  • Incorporation Date

    21 April 1998

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 28 Year, 30 Days
  • Last Filing with ROC 31 Mar 2025
Company report

Maks Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Maks Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Maks Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Anju Aggarwal Director 25 Dec 2000 Current
Madhusudan Agarwal Director 21 Apr 1998 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Jan 2012 Past
Pramod Abcsdd Director 05 Jan 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Maks Pharmaceuticals.

Maks Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Maks Pharmaceuticals revenue growth over time
Maks Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Maks Pharmaceuticals?

In 2017, Maks Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Maks Pharmaceuticals?

Unlock and access historical data on people associated with Maks Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Maks Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maks Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Maks Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Maks Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Maks Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was recorded as a recent event.

  • Director Appointment

    The activity Anju Aggarwal was appointed as a Director was appointed as a Director on 25 Dec 2000 & has been associated with this company since 25 years 4 months . was completed.

  • Director Appointment

    The activity Madhusudan Agarwal was appointed as a Director was appointed as a Director on 21 Apr 1998 & has been associated with this company since 28 years 30 days . was completed.

  • Company Incorporation

    The activity Maks Pharmaceuticals Private Limited was registered on 21 Apr 1998 with Roc Delhi I & aged 28 years 30 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Maks Pharmaceuticals Private Limited?

The CIN of Maks Pharmaceuticals Private Limited is U24232DL1998PTC093355.

Where is Maks Pharmaceuticals Private Limited headquartered?

Maks Pharmaceuticals Private Limited is headquartered at H-47 Naveen Shahdara, New Delhi, Delhi, 110032.

When was Maks Pharmaceuticals Private Limited incorporated?

Maks Pharmaceuticals Private Limited was incorporated on 21 April 1998.

Who are the current directors of Maks Pharmaceuticals Private Limited?

The current directors of Maks Pharmaceuticals Private Limited are

What is the primary industry of Maks Pharmaceuticals Private Limited?

The primary industry of Maks Pharmaceuticals Private Limited is Manufacturing.

Is Maks Pharmaceuticals Private Limited a listed company?

Maks Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Maks Pharmaceuticals Private Limited?

The authorized capital of Maks Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Maks Pharmaceuticals Private Limited?

The compliance status of Maks Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available